Rafael Franco

Prof. Rafael Franco

Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Catalonia, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Progress in Neurobiology
Verified
Journal Article
Closed access
Rafael FrancoRafael Franco
Rafael Franco
DFDiana Fernández-Suárez
Diana Fernández-Suárez

15 February 2006 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
FCFrancisco Ciruela
Francisco Ciruela
VCVicent Casadó
Vicent Casadó
Ricardo J RodriguesRicardo J Rodrigues
Ricardo J Rodrigues
RLRafael Luján
Rafael Luján
JBJavier Burgueño
Javier Burgueño
Rafael FrancoRafael Franco
Rafael Franco
The functional role of heteromers of G-protein-coupled receptors is a matter of debate. In the present study, we demonstrate that heteromerization of adenosine A1receptors (A1Rs) and A2Areceptors (A2ARs) allows adenosine to exert a fine-tuning modulation of glutamatergic neurotransmission. By means of coimmunoprecipitation, bioluminescence and time-resolved fluorescence resonance energy transfer techniques, we showed the existence of A1R–A2AR heteromers in the cell surface of cotransfected cells. Immunogold detection and coimmunoprecipitation experiments indicated that A1R and A2AR are colocalized in the same striatal glutamatergic nerve terminals. Radioligand-binding experiments in cotransfected cells and rat striatum showed that a main biochemical characteristic of the A1R–A2AR heteromer is the ability of A2AR activation to reduce the affinity of the A1R for agonists. This provides a switch mechanism by which low and high concentrations of adenosine inhibit and stimulate, respectively, glutamate release. Furthermore, it is also shown that A1R–A2AR heteromers constitute a unique target for caffeine and that chronic caffeine treatment leads to modifications in the function of the A1R–A2AR heteromer that could underlie the strong tolerance to the psychomotor effects of caffeine.

1 May 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JHJoëlle Hillion
Joëlle Hillion
MCMeritxell Canals
Meritxell Canals
MTMaria Torvinen
Maria Torvinen
VCVicent Casadó
Vicent Casadó
RSRizaldy Scott
Rizaldy Scott
KFKjell Fuxe
Kjell Fuxe
Antagonistic and reciprocal interactions are known to exist between adenosine and dopamine receptors in the striatum. In the present study, double immunofluorescence experiments with confocal laser microscopy showed a high degree of colocalization of adenosine A2A receptors (A2AR) and dopamine D2 receptors (D2R) in cell membranes of SH-SY5Y human neuroblastoma cells stably transfected with human D2R and in cultured striatal cells. A2AR/D2R heteromeric complexes were demonstrated in coimmunoprecipitation experiments in membrane preparations from D2R-transfected SH-SY5Y cells and from mouse fibroblast Ltk− cells stably transfected with human D2R (long form) and transiently cotransfected with the A2AR double-tagged with hemagglutinin. Long term exposure to A2AR and D2R agonists in D2R-cotransfected SH-SY5Y cells resulted in coaggregation, cointernalization and codesensitization of A2AR and D2R. These results give a molecular basis for adenosine-dopamine antagonism at the membrane level and have implications for treatment of Parkinson's disease and schizophrenia, in which D2R are involved.

1 November 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MCMeritxell Canals
Meritxell Canals
DMDaniel James Marcellino
Daniel James Marcellino
FFFrancesca Fanelli
Francesca Fanelli
FCFrancisco Ciruela
Francisco Ciruela
PBPiero de Benedetti
Piero de Benedetti
Rafael FrancoRafael Franco
Rafael Franco
There is evidence for strong functional antagonistic interactions between adenosine A2A receptors (A2ARs) and dopamine D2 receptors (D2Rs). Although a close physical interaction between both receptors has recently been shown using co-immunoprecipitation and co-localization assays, the existence of a A2AR-D2R protein-protein interaction still had to be demonstrated in intact living cells. In the present work, fluorescence resonance energy transfer (FRET) and bioluminescence resonance energy transfer (BRET) techniques were used to confirm the occurrence of A2AR-D2R interactions in co-transfected cells. The degree of A2AR-D2R heteromerization, measured by BRET, did not vary after receptor activation with selective agonists, alone or in combination. BRET competition experiments were performed using a chimeric D2R-D1R in which helices 5 and 6, the third intracellular loop (I3), and the third extracellular loop (E3) of the D2R were replaced by those of the dopamine D1 receptor (D1R). Although the wild type D2R was able to decrease the BRET signal, the chimera failed to achieve any effect. This suggests that the helix 5-I3-helix 6-E3 portion of D2R holds the site(s) for interaction with A2AR. Modeling of A2AR and D2R using a modified rhodopsin template followed by molecular dynamics and docking simulations gave essentially two different possible modes of interaction between D2R and A2AR. In the most probable one, helix 5 and/or helix 6 and the N-terminal portion of I3 from D2R approached helix 4 and the C-terminal portion of the C-tail from the A2AR, respectively.

11 July 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SGSílvia Gines
Sílvia Gines
JHJoëlle Hillion
Joëlle Hillion
MTMaria Torvinen
Maria Torvinen
SCStèphane Le Crom
Stèphane Le Crom
VCVicent Casadó
Vicent Casadó
Rafael FrancoRafael Franco
Rafael Franco
The possible molecular basis for the previously described antagonistic interactions between adenosine A 1 receptors (A 1 R) and dopamine D 1 receptors (D 1 R) in the brain have been studied in mouse fibroblast Ltk − cells cotransfected with human A 1 R and D 1 R cDNAs or with human A 1 R and dopamine D 2 receptor (long-form) (D 2 R) cDNAs and in cortical neurons in culture. A 1 R and D 1 R, but not A 1 R and D 2 R, were found to coimmunoprecipitate in cotransfected fibroblasts. This selective A 1 R/D 1 R heteromerization disappeared after pretreatment with the D 1 R agonist, but not after combined pretreatment with D 1 R and A 1 R agonists. A high degree of A 1 R and D 1 R colocalization, demonstrated in double immunofluorescence experiments with confocal laser microscopy, was found in both cotransfected fibroblast cells and cortical neurons in culture. On the other hand, a low degree of A 1 R and D 2 R colocalization was observed in cotransfected fibroblasts. Pretreatment with the A 1 R agonist caused coclustering (coaggregation) of A 1 R and D 1 R, which was blocked by combined pretreatment with the D 1 R and A 1 R agonists in both fibroblast cells and in cortical neurons in culture. Combined pretreatment with D 1 R and A 1 R agonists, but not with either one alone, substantially reduced the D 1 R agonist-induced accumulation of cAMP. The A 1 R/D 1 R heteromerization may be one molecular basis for the demonstrated antagonistic modulation of A 1 R of D 1 R receptor signaling in the brain. The persistence of A 1 R/D 1 R heteromerization seems to be essential for the blockade of A 1 R agonist-induced A 1 R/D 1 R coclustering and for the desensitization of the D 1 R agonist-induced cAMP accumulation seen on combined pretreatment with D 1 R and A 1 R agonists, which indicates a potential role of A 1 R/D 1 R heteromers also in desensitization mechanisms and receptor trafficking.

1 March 2009 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
SFSergi Ferre
Sergi Ferre
RBRuben Baler
Ruben Baler
MBMichel Bouvier
Michel Bouvier
MCMarc G Caron
Marc G Caron
LDLakshmi A Devi
Lakshmi A Devi
Rafael FrancoRafael Franco
Rafael Franco